Search Results - "Rabea, Hoda"

Refine Results
  1. 1

    The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients by Elhini, Sahar H, Wahsh, Engy A, Elberry, Ahmed A, El Ameen, Nadia F, Abdelfadil Saedii, Ahmed, Refaie, Shereen Mahmoud, Elsayed, Asmaa A, Rabea, Hoda M

    Published in Pharmaceuticals (Basel, Switzerland) (01-12-2022)
    “…Non-alcoholic fatty liver disease (NAFLD) is related to metabolic syndrome via insulin resistance, where preventing disease progression is crucial in the…”
    Get full text
    Journal Article
  2. 2

    The impact of mindfulness-based stress reduction on psychological health among patients with chronic diseases during COVID-19 outbreak lockdown by Osama, Hasnaa, Rabea, Hoda M., Abdelrahman, Mona A.

    “…Background The emergence of COVID-19 has spurred a wide range of psychological morbidities. However, its influence on a vulnerable population with chronic…”
    Get full text
    Journal Article
  3. 3

    The preparedness and knowledge of pharmacists and general practitioners in managing human monkeypox: a highly spreading infectious disease by Elsayed, Asmaa A, Rabea, Hoda M, Salman, Salman Ahmed, Wahsh, Engy A

    “…Background After the era of the COVID-19 pandemic, the role of pharmacists was emphasized in the battle against highly spreading and infectious diseases like…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Target Blood Pressure and Combination Therapy: Focus on Angiotensin Receptor Blockers Combination with Either Calcium Channel Blockers or Beta Blockers by Farag, Selvia M, Rabea, Hoda M, Abdelrahim, Mohamed Ea, Mahmoud, Hesham B

    Published in Current hypertension reviews (01-01-2022)
    “…The target blood pressure has changed many times in the guidelines in past years. However, there is always a question; is it good to lower blood pressure below…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure by Farag, Selvia M., Rabea, Hoda M., Mahmoud, Hesham B.

    “…Introduction Although hypertensive drugs may have the same effect on peripheral blood pressure, they vary in their effect on central blood pressure and its…”
    Get full text
    Journal Article
  12. 12

    Efficacy and Safety of Ombitasvir plus Paritaprevir, Ritonavir and Ribavirin in Non-cirrhotic Treatment-naïve and Treatment-experienced Egyptians with Chronic HCV Genotype-4 Infection by Ahmed, Manar, Mansey, Azza E., Wahsh, Engy A., Gomaa, Ahmed A., Rabea, Hoda M.

    Published in Current medical science (01-06-2021)
    “…Summary Hepatitis C virus genotype 4 (HCV-GT4) is a risk factor for cirrhosis, hepatocellular carcinoma and liver failure. A combination of three new…”
    Get full text
    Journal Article
  13. 13

    Effect of Amlodipine/Nebivolol combination therapy on central BP and PWV compared to Amlodipine/Valsartan combination therapy by Sultan, El-Zahraa M., Rabea, Hoda, Elberry, Ahmed A., Mahmoud, Hesham B.

    Published in The Egyptian heart journal (14-03-2022)
    “…Background Pulse wave velocity (PWV) and central blood pressure (CBP) have been intoduced into managment of hypertensive patients. PWV is positively correlated…”
    Get full text
    Journal Article
  14. 14

    Aerosol delivery aspects within a high-flow therapy system in COPD patients by Madney, Yasmin M, Laz, Nabila Ibrahim, Elberry, Ahmed A, Rabea, Hoda, Abdelrahim, Mohamed E A

    Published in ERJ open research (01-01-2021)
    “…There is a lack of information about the influence of patient interfaces such as facemasks or mouthpieces on the effective dose of aerosolised drugs while…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach by Sultan, El-Zahraa M., Rabea, Hoda M., abdelmeguid, Khaled R., Mahmoud, Hesham B.

    Published in The Egyptian heart journal (01-03-2018)
    “…•There was a non-significant difference regarding LVEF and TIMI flow between both PPCI and PI.•Myocardium wall preservation was significant in early PI…”
    Get full text
    Journal Article
  17. 17

    Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients by Harb, Hadeer S., Laz, Nabila Ibrahim, Rabea, Hoda, Abdelrahim, Mohamed E.A.

    “…The aim of this study was to determine prevalence and possible clinical predictors of suboptimal peak inspiratory flow rate (PIFR) with different dry powder…”
    Get full text
    Journal Article
  18. 18

    Antibiotic misuse and compliance with infection control measures during COVID-19 pandemic in community pharmacies in Egypt by Elsayed, Asmaa A, Darwish, Samar F, Zewail, Moataz B, Mohammed, Marwa, Saeed, Haitham, Rabea, Hoda

    “…Globally, antibiotics misuse by the public has been reported in the era of COVID-19, despite the discouraging instructions of the World Health Organization,…”
    Get more information
    Journal Article
  19. 19

    Impact of Advanced Patient Counseling Using a Training Device and Smartphone Application on Asthma Control by Saeed, Haitham, Abdelrahim, Mohamed Ea, Rabea, Hoda, Salem, Heba F

    Published in Respiratory care (01-03-2020)
    “…Pressurized metered-dose inhalers (pMDIs) are among the most commonly used aerosol delivery devices. Poor lung deposition from a pMDI is often a result of…”
    Get full text
    Journal Article
  20. 20

    Effect of Human Error, Inhalation Flow, and Inhalation Volume on Dose Delivery from Ellipta® Dry-Powder Inhaler by Saeed, Haitham, Salem, Heba F., Rabea, Hoda, Abdelrahim, Mohamed E. A.

    Published in Journal of pharmaceutical innovation (15-09-2019)
    “…Purpose Ellipta® is a new dry-powder inhaler (DPI), with medium flow resistance. The present study aimed to evaluate Ellipta® dose preparation and inhalation…”
    Get full text
    Journal Article